. . . . . . . . . "a(SCHEM:\"Tetradecanoylphorbol acetate\") -> path(SDIS:\"oncogenic transformation\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "These results indicate a crucial role of PLCepsilon in ras oncogene-induced de novo carcinogenesis and downstream signaling from TPA, introducing PLCepsilon as a candidate molecular target for the development of anticancer drugs." . . "Selventa" . . . . "2014-07-03T14:30:30.453+02:00"^^ . . .